Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Yip

Showing results (81-90 of 212) with videos related to

Pageof 22
Sort By:
American Journal of Medical Genetics. Part A|November 18, 2015
Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansionKaren W Gripp, Katherine M Robbins, Brandon S Sheffield, et al.
BMC Cancer|February 7, 2015
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomasHector H Li-Chang, Katayoon Kasaian, Ying Ng, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Progress toward Health System Readiness for Genome-Based Testing in CanadaDon Husereau, Eva Villalba, Vivek Muthu, et al.
Translational Lung Cancer Research|September 21, 2020
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomesAlexandra Pender, Curtis Hughesman, Elaine Law, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness ReportDon Husereau, Filomena Servidio-Italiano, Monika Slovinec D'Angelo, et al.
Experimental and Molecular Pathology|October 4, 2011
Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniquesGulisa Turashvili, Winnie Yang, Steven McKinney, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous systemDerek Wong, Yaoqing Shen, Adrian B Levine, et al.
Oncotarget|October 11, 2012
Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomideJoanna Triscott, Cathy Lee, Kaiji Hu, et al.
Pageof 22

Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
American Journal of Medical Genetics. Part A|November 18, 2015
Paternal uniparental disomy 11p15.5 in the pancreatic nodule of an infant with Costello syndrome: Shared mechanism for hyperinsulinemic hypoglycemia in neonates with Costello and Beckwith-Wiedemann syndrome and somatic loss of heterozygosity in Costello syndrome driving clonal expansionKaren W Gripp, Katherine M Robbins, Brandon S Sheffield, et al.
BMC Cancer|February 7, 2015
Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomasHector H Li-Chang, Katayoon Kasaian, Ying Ng, et al.
Lancet Regional Health. Americas|November 28, 2024
Real-world cost-effectiveness of multi-gene panel sequencing to inform therapeutic decisions for advanced non-small cell lung cancer: a population-based studyEmanuel Krebs, Deirdre Weymann, Cheryl Ho, et al.
Current Oncology (Toronto, Ont.)|June 27, 2023
Progress toward Health System Readiness for Genome-Based Testing in CanadaDon Husereau, Eva Villalba, Vivek Muthu, et al.
Translational Lung Cancer Research|September 21, 2020
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomesAlexandra Pender, Curtis Hughesman, Elaine Law, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Readiness to Consider and Adopt Genetic and Genomic Tests in Canada-An Update to the State of Readiness ReportDon Husereau, Filomena Servidio-Italiano, Monika Slovinec D'Angelo, et al.
Experimental and Molecular Pathology|October 4, 2011
Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniquesGulisa Turashvili, Winnie Yang, Steven McKinney, et al.
Cold Spring Harbor Molecular Case Studies|August 3, 2019
The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous systemDerek Wong, Yaoqing Shen, Adrian B Levine, et al.
Oncotarget|October 11, 2012
Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomideJoanna Triscott, Cathy Lee, Kaiji Hu, et al.
Pageof 22